Bronfman E.l. Rothschild »

Galectin Therapeutics shares owned by Bronfman E.l. Rothschild

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Bronfman E.l. Rothschild from 13F filings

Historical chart of Bronfman E.l. Rothschild investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Bronfman E.l. Rothschild consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Bronfman E.l. Rothschild

Quarter filed Position value Share count Share price at filing
2020-09-30 $37k 14k 2.67

More positions owned by Bronfman E.l. Rothschild

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Intl Ftse Dev Mkt Etf (VEA)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Index Fds Extend Mkt Etf (VXF)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Small Cp Etf (VB)

View all positions for Bronfman E.l. Rothschild

Top funds holding Galectin Therapeutics

Vanguard Group
BlackRock
Affinity Asset Advisors
Advisor Group Holdings
Ikarian Capital
Geode Capital Management
Commonwealth Equity Services
Sontag Advisory
Geneos Wealth Management
Susquehanna International
Boothbay Fund Management
State Street Corporation
Northern Trust
Atria Wealth Solutions
Sovran Advisors

View all funds holding Galectin Therapeutics